United Therapeutics (UTHR) Shares Outstanding (Diluted) (2009 - 2026)
United Therapeutics (UTHR) Shares Outstanding (Diluted) (2009 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | 4.46 Bn |
| 2 | Teva Pharmaceutical Industries | 43.31 Bn | 39.66 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 31.65 Bn | 29.98 Bn | 1.05 Bn | 417.70 Mn |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn | 1.58 Bn |
| 5 | United Therapeutics | 22.18 Bn | 19.52 Bn | 683.80 Mn | 45.80 Mn |
| 6 | Viatris | 18.82 Bn | 17.94 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.70 Bn | 15.31 Bn | 935.80 Mn | 104.20 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | 505.90 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | 833.33 Mn |
| 10 | Alkermes | 8.21 Bn | 7.55 Bn | 397.90 Mn | 173.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 45.80 Mn |
| Mar 31, 2026 | 47.20 Mn |
| Dec 31, 2025 | 47.90 Mn |
| Sep 30, 2025 | 47.30 Mn |
| Jun 30, 2025 | 48.30 Mn |
| Mar 31, 2025 | 48.60 Mn |
| Dec 31, 2024 | 48.50 Mn |
| Sep 30, 2024 | 48.40 Mn |
| Jun 30, 2024 | 47.50 Mn |
| Mar 31, 2024 | 49.70 Mn |
| Dec 31, 2023 | 49.70 Mn |
| Sep 30, 2023 | 49.70 Mn |
| Jun 30, 2023 | 49.50 Mn |
| Mar 31, 2023 | 49.60 Mn |
| Dec 31, 2022 | 48.50 Mn |
| Sep 30, 2022 | 48.70 Mn |
| Jun 30, 2022 | 48.10 Mn |
| Mar 31, 2022 | 47.70 Mn |
| Dec 31, 2021 | 47.30 Mn |
| Sep 30, 2021 | 47.60 Mn |